PVI
CYCN icon

Pura Vida Investments’s Cyclerion Therapeutics CYCN Stock Holding History

Pura Vida Investments’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-38,825
Closed -$862K – 228
2022
Q1 		$862K Buy
38,825
+240
+0.6% +$5.78K 0.03% 188
2021
Q4 		$1.33M Buy
38,585
+17,469
+83% +$825K 0.05% 163
2021
Q3 		$1.3M Sell
21,116
-4,258
-17% -$279K 0.04% 209
2021
Q2 		$1.98M Buy
+25,374
New +$1.59M 0.06% 160

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Pura Vida Investments's CYCN Position: Q2 2022 in Review

Pura Vida Investments sold out of Cyclerion Therapeutics (CYCN) in Q2 2022, closing a stake of 38,825 shares — an estimated $862K sold.

Pura Vida Investments first reported a position in CYCN in Q2 2021 and held it in 4 quarters. The position peaked at $1.98M in Q2 2021. 41 funds tracked by Wall St. Rank hold CYCN as of Q2 2022.

  • Pura Vida Investments reported no remaining Cyclerion Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 38,825 Cyclerion Therapeutics shares in Q2 2022, an estimated $862K.
  • Pura Vida Investments first reported a position in Cyclerion Therapeutics in Q2 2021 and held it in 4 quarters.
  • Pura Vida Investments's Cyclerion Therapeutics position peaked at $1.98M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.